The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the healthcare networks.
Specifically, the contract covers the supply of Orphenadrine Citrate 100mg Sustained Action Tablets, with an estimated annual requirement of 1,672 bottles. The contract was awarded by the National Acquisition Center, a civilian federal agency, with no set-asides, and the products will be distributed through the VA's prime vendor program to VA medical centers, DoD, Bureau of Prisons, and Indian Health Services facilities. The contract was originally solicited through a pre-solicitation notice, which provided details on the scope, NAICS code, and point of contact for interested offerors.
Generated 1/3/25, 9:09 AM